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Abstract 
The transcriptional start sequence of pneumonia virus of mice is more variable than that of 
the other pneumoviruses, with five different nine-base gene start (GS) sequences found in the 
PVM genome.  The sequence requirements of the PVM gene start signal, and the efficiency 
of transcriptional initiation of the different virus genes, was investigated using a reverse 
genetics approach with a minigenome construct containing two reporter genes.  A series of 
GS mutants were created, where each of the nine bases of the gene start consensus sequence 
of a reporter gene was changed to every other possible base, and the resulting effect on 
initiation of transcription was assayed.  Nucleotide positions 1, 2 and 7 were found to be most 
sensitive to mutation whilst positions 4, 5 and 9 were relatively insensitive.  The L gene GS 
sequence was found to have only 20% of the activity of the consensus sequence whilst the 
published M2 gene start sequence was found to be non-functional.  A minigenome construct 
in which the two reporter genes were separated by the F-M2 gene junction of PVM was used 
to confirm the presence of two alternative, functional, GS sequences that could both drive the 
transcription of the PVM M2 gene.  
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Pneumonia virus of mice (PVM) is a member of the family Paramyxoviridae, subfamily 
Pneumovirinae and is in the Pneumovirus genus.  PVM is closely related to human 
respiratory syncytial virus (RSV) and is currently being developed as an animal model for 
RSV (Bonville et al., 2003; Cook et al., 1998; Domachowske et al., 2000a; Domachowske et 
al., 2002; Domachowske et al., 2000b; Thorpe and Easton, 2005).  PVM has a single stranded, 
non-segmented, negative sense RNA (NNS-RNA) genome of between 14,885 (Strain J3666) 
and 14,887 (Strain 15) nucleotides in length (Thorpe and Easton, 2005:  Accession numbers 
AY743909 and AY743910).  The genome RNA encodes ten genes as individual transcription 
units and generates eleven major protein products (Ahmadian et al., 1999; Chambers et al., 
1990a; Chambers et al., 1990b; Thorpe and Easton, 2005).  The gene order and the major 
proteins expressed during PVM infection are similar to those in RSV, the main distinction 
being that the M2 and L genes of RSV overlap by 68 nucleotides whereas the M2 and L 
genes of PVM are separated by a distinct intergenic region (Chambers et al., 1990b; Collins 
et al., 1987).  The presence of the overlap in RSV results in premature termination of L gene 
mRNA at the M2 gene end so reducing the level of full length L gene mRNA (Collins et al., 
1987). 
NNS-RNA virus RNA synthesis is carried out by the viral RNA-dependent RNA 
polymerase, which always initially binds the leader region at the 3’ terminus of the genome.  
The minimal competent unit for transcription in NNS-RNA viruses is the ribonucleoprotein 
complex, consisting of viral genomic RNA complexed with the nucleoprotein (N), the 
phosphoprotein (P) and the large polymerase protein (L).  In pneumoviruses an additional 
protein, the M2-1 protein, acts as a transcription elongation factor (Collins et al., 1996; 
Grosfeld et al., 1995).  Transcription of pneumovirus genes is controlled by initiation at a 
nine nucleotide consensus transcription initiation sequence called a gene start (GS), with 
termination at a consensus 13-16 nucleotide transcription termination sequence called a gene 
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end (GE).  Transcription progresses in a sequential interrupted fashion along the length of the 
genome whereby termination of transcription at the GE leads to either dissociation of the 
polymerase from the template or re-initiation of transcription at the subsequent GS sequence 
(Collins et al., 1986).  This results in the abundance of mRNA species being controlled by 
both proximity of a gene to the 3’ terminus of the genome, and efficiency of re-initiation of 
transcription at the gene start sequence (Dickens et al., 1984; Iverson and Rose, 1981; Pringle 
and Easton, 1997).  In recent years it has become apparent that the initiation of transcription 
at GS sequences may depend on the precise nature of the sequence.  Both RSV and avian 
pneumovirus (APV) possess a highly conserved GS sequence, only varying in sequence in 
the GS which directs transcription of the L gene (Chambers et al., 1990b; Collins et al., 1986; 
Li et al., 1996; Ling et al., 1995; Ling et al., 1992; Randhawa et al., 1996; Yu et al., 1991; Yu 
et al., 1992).  In contrast, the PVM GS has one of five possible sequences (Table 1), the 
consensus sequence being AGGAyAArT, suggesting the possibility of differential expression 
of genes or a tolerance of variation in GS sequence (Chambers et al., 1990a; Chambers et al., 
1990b).  The GS sequences of both APV and RSV have been subjected to mutational analysis 
that identified residues important for the initiation of transcription (Edworthy and Easton, 
2005; Kuo et al., 1997).  Here, we describe a similar analysis of the role of each of the nine 
individual bases of the PVM GS sequence using a reverse genetics approach. 
To assess the efficiency of initiation of transcription by different mutants of the PVM 
GS signal a dicistronic minigenome was constructed (Figure 1), containing two genes, similar 
to those described previously for APV and RSV (Edworthy and Easton, 2005; Kuo et al., 
1996).  The first gene in the PVM minigenome encoded bacterial chloramphenicol acetyl 
transferase (CAT) and was flanked by the N gene GS signal (AGGATAAAT) and the L gene 
GE signal (TAGTTAACAAAAAA).  The second gene encoded enhanced green fluorescent 
protein (EGFP) and was also flanked by the N gene GS sequence and the L gene GE 
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sequence.  The N gene GS sequence was used as it most closely resembled the consensus GS 
sequence.  The intergenic region separating the two genes was that of the N-P gene junction, 
modified to contain a BglII site for cloning purposes (TGAGATCTGT (BglII site 
underlined)).  For the construction, two monocistronic minigenomes were constructed, one 
containing the CAT gene (pKozmg) and one the EGFP gene (pEGFPmg: Figure 1), these 
were then fused together to produce a dicistronic construct.  The second cistron of the 
dicistronic construct pCAT-EGFPmg was synthesised by PCR from the EGFP minigenome 
pEGFPmg.  Primers CATEGFP 1 (all primers used in the construction of the various 
minigenomes are shown in Table 2) and CATEGFP 3 were used to amplify the EGFP gene 
along with, at the 3’ end, the PVM N gene GS sequence with the addition of an intergenic 
region, and at the 5’ end the L gene GE sequence.  This second cistron was inserted into the 
CAT minigenome pKozmg, downstream of the CAT gene to create a dicistronic construct.  
Every position of the EGFP reporter gene GS signal was mutated to each of the three other 
possible bases using either quickchange mutagenesis (Stratagene) or standard two-step PCR 
mutagenesis, as described previously (Edworthy and Easton, 2005), resulting in a set of 28 
mutants plus the N GS control construct.  Mutagenic primers of 48 nucleotides in length were 
used for both techniques (all mutagenic primer sequences are available from authors on 
request). For two-step PCR mutagenesis, flanking primers GSA, containing an NcoI 
restriction site, and GSB, containing a NotI restriction site, were used to produce an insert 
with a mutated GS sequence that could be ligated into the parental plasmid pCAT-EGFPmg. 
The dicistronic minigenome construct was transfected into BSRT-7 cells (Buchholz et 
al., 1999) using Fugene6 transfection reagent (Roche) along with plasmids carrying the N, P, 
L and M2-1 genes of PVM Strain 15 (Thorpe and Easton, 2005).  The plasmids were 
transfected in the ratios (per 10
6
 cells), 0.4μg minigenome, 0.4μg N gene plasmid, 0.2μg P 
gene plasmid, 0.2μg L gene plasmid and 0.1μg M2-1 ORF plasmid.  The effect on initiation 
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of transcription from the mutant GS sequences was monitored by measuring changes in levels 
of EGFP protein expression.  Both CAT (Marriott et al., 2001) and EGFP protein levels were 
assayed by ELISA, and the level of EGFP protein expressed for each mutant was calculated 
as a percentage of that seen with the intact N GS sequence.  The data were then normalised 
using levels of CAT protein expression derived from the non-mutated first cistron as 
described previously (Edworthy and Easton, 2005). 
 Relative levels of EGFP protein expression derived from each mutant are shown in 
figure 2.  All mutations made to the GS signal resulted in a decrease in expression of EGFP 
protein, with the level of the decrease varying greatly between different mutants.  Certain 
positions in the PVM GS signal were particularly tolerant or intolerant to mutation.  As can 
be seen, positions 1, 2 and 7 of the PVM GS sequence were intolerant to mutation as any 
nucleotide substitution at these positions resulted in almost complete loss of EGFP protein 
expression, suggesting that mutation in these locations results in the abrogation of binding of 
the viral polymerase complex to the GS sequence.  In contrast, positions 4, 5 and 9 of the 
PVM GS signal appeared to be more tolerant of mutation, with most nucleotide changes at 
these positions resulting in retention of more than of 20% of EGFP protein expression.  In the 
APV and RSV GS sequences, position 7 has previously been found to be highly sensitive to 
mutation, suggesting that this is an essential component in the initiation of transcription in all 
pneumoviruses.  As for PVM, position 5 has been shown to be more tolerant to mutation as in 
APV and RSV indicating that this is a common feature of the pneumovirus GS sequence 
(Edworthy and Easton, 2005; Kuo et al., 1997) 
Positions 3 and 8 of the PVM GS sequence displayed a preference for purines.  At 
position 3, substituting the conserved guanine residue for a pyrimidine resulted in the loss of 
almost all EGFP protein expression, while replacing it with adenine gave 40% of maximal 
expression.  Similarly, at position 8 substitution of conserved adenine for guanine generated 
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60% of maximal EGFP protein levels whereas substitution of a pyrimidine resulted in much 
greater decrease of EGFP protein expression.  This preference for either pyrimidine or purine 
at specific locations has also been observed for both RSV and APV.  Position 8 in both PVM 
and RSV GS sequences display a similar pattern of sensitivity to mutation, with substitution 
of a purine for a purine (PVM) or a pyrimidine for a pyrimidine (RSV), resulting in 
conservation of activity, while any other change abolishes activity.  Position 9 of the PVM 
GS signal was relatively tolerant to sequence change, with EGFP protein expression levels of 
between 22% and 56% of maximal levels for all mutations, whereas position 9 of both APV 
and RSV GS signals have been shown to be very sensitive to mutation (Edworthy and Easton, 
2005; Kuo et al., 1997). 
To confirm that the changes in protein expression observed were due to changes in the 
efficiency of initiation of transcription, rather than an independent effect on translation, the 
levels of mRNA synthesised from both reporter genes by a selection of mutants were 
analysed (Figure 3).  A series of mutants were chosen to represent those affected either only 
slightly, moderately or severely by the mutations.  Transfections were conducted as above but 
48 hours post-transfection, mRNA was purified from the cells using a Sigma GenElute™ 
Direct mRNA Miniprep Kit.  Purified mRNA was separated on a glyoxal-agarose gel and 
detected by northern blotting using non-radioactive DIG-labelled riboprobes specific for both 
CAT and EGFP (Marriott et al., 1999).  CAT mRNA levels remained constant for the various 
mutants examined, as expected.  However, the levels of EGFP mRNA detected varied in 
conjunction with changes in EGFP protein expression.  These data confirmed that the 
changes in EGFP protein expression were due to variations in the efficiency of transcription 
as a result of the mutations introduced into the GS sequence.  Uniform levels of read-through 
mRNA confirmed that alterations to the EGFP GS signal were not affecting the processivity 
of the polymerase across the gene junction. 
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The series of mutants described here includes all GS sequences present in the PVM 
genome (Table 1).  From comparison of these sequences with the mutants analysed several 
observations can be made.  Firstly, the GS sequence used by the NS1 and NS2 genes contains 
two deviations from the N GS sequence (U5C and A8G), resulting in 45% lower expression.  
The individual mutants U5C and A8G result in a similar drop in protein expression (Figure 2), 
showing that the two differences in sequence are not cumulative.  Secondly, eight of the ten 
GS sequences found in the PVM genome are either identical to the N GS sequence used here 
or contain the changes U5C or A8G, both of which are still relatively efficiently transcribed.  
Thus, although the PVM GS sequence is more variable than those of RSV and APV, the 
variations do not have a dramatic effect on the efficiency of transcription of virus genes.  This 
indicates that the majority of the variability seen in the PVM GS sequence is tolerated by the 
virus polymerase and does not provide a significant method of regulation of virus genes.  
However, due to the sequential transcription of genes the cumulative effect of these moderate 
decreases in transcription across several gene junctions could result in significant down-
regulation of transcription from promoter-distal genes.  The other two GS sequences 
occurring naturally in the PVM genome are the L gene (A6C compared to the N GS) and the 
M2 gene (A6G and A8G compared to the N GS: Table 1) GS signals.  The L gene GS of 
PVM is only 20% as active as the N gene GS (indicated by an asterisk in Figure 2).  This 
contrasts with the APV and RSV L gene GS sequences which were more divergent in 
sequence from the consensus (each containing three nucleotide differences) but which 
resulted in protein expression levels of 50% and 100%, respectively (Edworthy and Easton, 
2005; Kuo et al., 1997).  This suggests that attenuation of L gene expression due to a 
decreased efficiency of initiation of transcription is a more significant mode of regulation in 
PVM than either APV or RSV.  However, transcription of the RSV L gene is severely 
attenuated due to the presence of the M2/L gene overlap (Collins et al., 1987) and this results 
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in a level of expression of L mRNA much lower than would be predicted from the efficiency 
of the gene start sequence.  Surprisingly, based on the EGFP protein expression data reported 
here, the proposed PVM M2 GS sequence is non-functional, giving EGFP protein levels of 
only 0.5% of that seen with the N gene start sequence.  The A6G sequence contained in the 
putative M2 gene GS sequence, on its own, results in complete shutoff of EGFP protein 
expression.  The original assignment of the M2 gene start sequence was based on sequences 
derived from a cDNA library (Chambers et al., 1990b).  However, it had been previously 
noted that the 5’ end sequences in cDNA clones of PVM mRNAs frequently contained an 
inversion due to the presence of inverted repeats (Barr et al., 1991) and this may have led to a 
misidentification of the 5’ end of the M2 mRNA.  Given the potential role of the M2 gene 
products in pneumovirus gene expression and the likely consequential effect on L gene 
expression a significant down regulation of PVM M2 gene transcription of this order 
appeared unlikely.  These data therefore suggested that the M2 GS sequence of PVM may 
have been originally assigned incorrectly and that the real M2 GS signal is more active.  
Consideration of the PVM genome sequence identified two sequences upstream of the 
designated M2 GS signal, and within the sequence previously identified as the intergenic 
region between the F and M2 genes, that fit the consensus sequence and may therefore act as 
GS signals (Figure 4A).  These have the sequences AGGAUAAGU (-53 bases, referred to 
here as GS1) and AGGAUAAGG (-10 bases upstream, referred to here as GS2).  Either of 
these sequences could potentially function as a GS signal, the GS1 sequence having only an 
A8G substitution and the GS2 sequence containing the sequence changes A8G and U9G, 
neither of which are overly detrimental to transcription while, as indicated in Table 1 the 
previously identified M2 GS sequence, contains the alterations A6G and U8G and is 
designated as GS3 below. 
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To investigate the contribution of each of these sequences to the initiation of 
transcription of the PVM M2 gene a dicistronic minigenome construct containing the F-M2 
intergenic region, designated pF-M2GS, was used.  Transcription of the EGFP gene in this 
construct was therefore under the control of all three putative M2 GS sequences.  The F-M2 
IG region was amplified using primers CATEGFP-M2GSA and CATEGFP-M2GSD (Table 
2).  The EGFP gene of pCAT-EGFPmg was amplified using primers CATEGFP-M2GSC and 
CATEGFP 3 and these DNA fragments were fused together by overlap PCR using primers 
CATEGFP-M2GSA and CATEGFP 3.  The resulting product was inserted into pCAT-
EGFPmg and the L gene GE sequence of the CAT gene was corrected to an F GE sequence 
by quickchange mutagenesis, using primers L-FGE+ and L-FGE-.  This plasmid, designated 
pF-M2IG, contained three GS sequences, GS1, GS2 and GS3.  The role of each alternate GS 
sequence in transcription was assessed as described for the other GS mutants, only the levels 
of EGFP protein expression were calculated as a percentage of that given with all three GS 
sequences intact. 
The F-M2 intergenic region gave levels of EGFP protein expression of almost 10% of 
that given by the N GS positive control (Figure 2).  This confirmed that the intergenic region 
containing all three M2 GS sequences could drive expression of EGFP protein and was 
significantly more efficient at initiating transcription than GS3 alone.  For the purpose of this 
analysis GS3 was considered to be non-functional as it gave levels of EGFP protein 
expression only marginally above background (Figure 2).  Given that the first gene start 
sequence (GS1) in the intergenic region contained only the mutation A8G which had 
previously been shown to reduce expression to 60% of that seen with the N gene start the 
observation that the entire intergenic region gave only 10% activity was unexpected.  Two 
possible explanations for this discrepancy are possible.  Firstly, there may be less efficient 
termination of transcription at the F gene end sequence compared to the level with the L gene 
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end sequence leading to different levels of reinitiation at the subsequent gene start.  The 
efficiency of termination at different gene end sequences has not been assessed.  Secondly, 
the lengths of the intergenic regions in the two constructs used are not identical and this may 
affect reinitiation frequency.  The first two sequences, GS1 and GS2, were individually 
mutated to non-functional GS sequences to assess the role of each in the initiation of 
transcription of the EGFP gene.  This was achieved by the introduction of an AG 
nucleotide change at residue 1 of the GS sequence by quickchange mutagenesis, with GS1 
mutated using primers GS1-A1G+ and GS1-A1G- and GS2 mutated using primers GS2-
A1G+ and GS2-A1G-.  As shown in Figures 2 and 3 the alteration of the first A residue of 
the consensus GS sequence completely ablated transcriptional activity.  The effect of the 
deletion of either GS1 or GS2 in the F-M2 intergenic region on EGFP protein expression is 
shown in Figure 4B.  The construct containing all three GS sequences is labeled M2GS-123.  
The construct with the mutated GS1 is labeled M2GS-23, and the construct with the mutated 
GS2 is labeled M2GS-13.  It can be seen that mutation of either GS1 or GS2 had a 
deleterious effect on the expression of EGFP protein.  In the absence of GS1 the level of 
EGFP protein expression dropped to approximately 25% of that seen with all three GS 
sequences.  In the absence of GS2 the decrease in EGFP protein expression was less dramatic, 
falling to approximately 60% of that with all three GS sequences.  This suggests that both 
GS1 and GS2 can initiate transcription but that GS1 is more important than GS2.  This agrees 
with the results obtained from the mutational analysis described above with the GS1 
sequence, containing only an A8G nucleotide substitution when compared to the consensus 
GS sequence, expected to more efficiently initiate transcription than the GS2 sequence, which 
contained both A8G and U9G nucleotide substitutions.  Overall, these data suggest that, the 
originally designated GS sequence of the M2 gene of PVM is not involved in transcription of 
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the M2 gene, and that two other upstream GS sequences could both contribute to the 
transcription of the M2 gene, with the first GS sequence being more important. 
In conclusion mutational analysis of the gene start sequence of PVM has shown that it, 
like the other pneumoviruses, is variable in its sensitivity to mutation.  Positions 1, 2 and 7 of 
the nine base sequence are highly intolerant to mutation, suggesting that these bases play an 
essential role in interaction with the viral polymerase complex during initiation of 
transcription.  Position 7 is also particularly sensitive to mutation in both APV and RSV, 
suggesting that this residue plays a key role in initiation of transcription across the 
pneumovirus sub-family.  Positions 4, 5 and 9 of the PVM GS sequence were found to be 
more tolerant to mutation, and of these, position 5 has been shown previously to be less 
sensitive to mutation in both APV and RSV (Edworthy and Easton, 2005; Kuo et al., 1997).  
Position nine of the PVM GS is tolerant to mutation, as is position 10 of the RSV GS (Kuo et 
al., 1997), and this contrasts with APV where the terminal base of the GS was shown to be 
sensitive to mutation (Edworthy and Easton, 2005).  This identifies a possible distinction 
between the different genera of the Pneumovirinae, the 5’ nucleotides of the GS being less 
important in polymerase binding in pneumoviruses than in metapneumoviruses.  Comparing 
the figures of relative protein expression levels produced for all three viruses, it can be seen 
that the most sensitive areas of the pneumovirus GS sequences cluster around bases 1, 2, 6 
and 7, identifying these regions as being important in the initiation of transcription, with the 
central region of the sequence seemingly playing less of a role.  
The M2 gene GS sequence of PVM was identified as having only minimal activity in 
the initiation of transcription.  Two alternative sequences were identified upstream of the 
designated M2 GS sequence which could potentially act as GS signals (designated GS1 and 
GS2).  These factors suggested that the GS sequence of the PVM M2 gene was originally 
assigned incorrectly.  The first GS sequence (GS1) following the F GE sequence appears to 
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be most important.  This fits with the proposed mechanism for transcription where following 
termination of transcription the polymerase complex moves along the genome template until 
it encounters the next available GS sequence at which it can initiate transcription of the next 
gene. 
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FIGURE LEGENDS 
 
Table 1. The gene start sequences of the 10 genes of PVM are more variable than those 
of other pneumoviruses.  The nine residue sequence is conserved across six of the 
nine positions but is variable at positions 5, 6 and 8.  Conserved residues are shaded 
and the consensus gene start sequences is shown. 
Table 2. Sequences of oligonucleotide primers used in the construction of PVM 
minigenomes. 
Figure 1. Diagram of construction of the PVM dicistronic minigenome.  The DNA 
minigenome construct contained two reporter genes, CAT and EGFP, as separate 
transcription units derived from separate monocistronic minigenome constructs, and 
produced a genome sense RNA from T7 transcription.  Both genes were under the 
control of PVM consensus gene start (GS) and gene end (GE) signals and were 
flanked by the PVM leader and trailer regions.  GS marked with * was mutated to 
allow assessment of effect of mutations on the transcription of the EGFP gene.  T7 
transcription gives rise to a negative sense minigenome RNA with termini defined by 
the T7 promoter (5') and HDV ribozyme (3').  Plasmid encoded RNP components 
encapsidate, transcribe and replicate the minigenome RNA.  RNA synthesis always 
initiates at the leader region of the negative sense RNA and results in synthesis of 
either mRNA, defined by the GS and GE sequences, or full length anti-minigenome 
RNA. 
Figure 2. Figure showing relative expression of EGFP protein for all GS mutants.  The 
wild-type (N gene) GS sequence is displayed below the x axis (AGGAUAAAU), 
while nucleotide changes at each position are shown on the x axis.  Levels of EGFP 
protein expression are displayed as percentage of that produced by the consensus GS 
sequence (NGS – black bar), and are averages of three independent experiments.  
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Gene start sequences present in the PVM genome containing more than one 
nucleotide change from the wild-type are shown with white bars (NS1/NS2, M2).  Bar 
labelled with * is the mutation corresponding to the L gene GS sequence.  Results 
obtained using a construct containing the PVM F-M2 gene junction are shown with 
diagonal shading (designated F-M2 IG).   
Figure 3. Comparison of relative EGFP protein expression with EGFP mRNA levels for 
a selection of mutants.  Northern blot analysis was used to detect both CAT mRNA 
and EGFP mRNA produced by each mutant construct, with CAT mRNA acting as an 
internal control for initiation of transcription from the leader sequence.  
Figure 4. Figure showing the sequences of, and relative EGFP protein expression from, 
three putative GS sequences of the PVM M2 gene.   
A.  Sequence of the PVM F-M2 intergenic region.  Sequences are shown as positive 
sense RNA.  The gene end of the F gene is shown in bold and the three putative M2 
gene start sequences GS1, GS2 and GS3 and underlined. 
B.  The efficiency of EGFP protein expression with either GS1 or GS2 deleted 
(M2GS-23 and M2GS-13, respectively) is shown as a percentage of that given with 
all three GS sequences (M2GS-123), shown as 100%.    
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Table 1. 
 
 
GENE 
GENE START 
SEQUENCE 
N, P and SH AGGAUAAAU 
NS1 and NS2 AGGACAAGU 
M and F AGGACAAAU 
G AGGAUAAGU 
M2 AGGAUGAGU 
L AGGAUCAAU 
Consensus AGGA U a AaA 
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Table 2. 
 
Oligonucleotide name Sequence 
CATEGFP 1 CGATGTTAACAAAAAACTGAGATCTGTAGGATAAATACATA 
TGGTGAGCAAG 
CATEGFP 3 GTGAGATATCAATTTTTTGTTAACTATA 
GSA CCCGTTTTCACCATGGGCAAATAT 
GSB TAGAGTCGCGGCCGCTTTACTTGT 
CATEGFP-M2GSA GCCGTAGTTAACAAAAAACTTAGGATAAGTGACAATCCAG 
CATEGFP-M2GSD CTCGCCCTTGCTCACACTCATCCTACCTTATCCTTGA 
CATEGFP-M2GSC TAAGGTAGGATGAGTGTGAGCAAGGGCGAGGAGCTGT 
L-FGE+ ATTATTTTAATTTGTCTATAGTTAATTAAAAACTTAGGATAA 
GTGACAATCC 
L-FGE- GGATTGTCACTTATCCTAAGTTTTTAATTAACTATAGACAAA 
TTAAAATAAT 
GS1-A1G+ TTTGTCTATAGTTAATTAAAAACTTGGGATAAGTGACAATCC 
AGACCCAAC 
GS1-A1G- GTTGGGTCTGGATTGTCACTTATCCCAAGTTTTTAATTAACTA 
TAGACAAA 
GS2-A1G+ GACCCAACACCTCTTTCAACTCTCAGGGATAAGGTAGGATGA 
GTGTGAGCA 
GS2-A1G- TGCTCACACTCATCCTACCTTATCCCTGAGAGTTGAAAGAGGT 
GTTGGGTC 
 
 
